skip to Main Content

Our mission is to provide customized surface technology solutions by combining best-in-class quality and customer service to support the development of medical devices that aid in improving patient outcomes.

We are a global leader in the development, manufacturing and application of hydrophilic (slippery) biomaterial coatings used in medical devices. Our coatings allow for medical devices to easily transverse through the body by minimizing friction as the material moves to its intended destination. Our custom coatings are lubricious, abrasion resistant, biocompatible and can be applied to a wide range of polymeric and metallic substrates.

1
Years of partnership
1
Countries covered worldwide
2016
ISO 13485:2016 Certified

Facilities & Locations

 

Biocoat’s headquarters are located in Horsham, PA, about 45 minutes outside of Philadelphia, PA. In May 2018, Biocoat officially opened our new facility at Rock Road, bringing our total square footage to 62,000 square feet. Biocoat has four Class 7 clean rooms, manufacturing, R&D and disaster recovery facilities all dedicated to the development and expert application of our coatings.

Our Leadership

The strength of an organization lies in its people. The team of experts at Biocoat, and its Board of Directors, is made up of leaders in the industry, clinical champions and innovative thinkers.

Jim Moran
President & CEO

Read Bio »

Steven Bell
Chief Financial Officer

Read Bio »

Peg Beavers
Executive Vice President

Read Bio »

Joe Sandora
Vice President, Business Development

Read Bio »

Dr. Robert Hergenrother
Senior Director, Research & Development

Read Bio »

Thomas Brugnoli
Senior Director of Operations

Read Bio »

Dhruv Patel
Senior Director, Technical Sales & Service

Read Bio »

Greg Kleinert
Senior Director, Quality Assurance

Read Bio »

Scott Cramer
Chairman of the Board
President & CEO, DNA Diagnostics Center

Read Bio »

Michael Koby
Founding Partner, 1315 Capital

Read Bio »

Matt Bastardi
SVP, Commercial & Strategy, Surgical Specialties Corporation

Read Bio »

Wes Kaupinen
President and CEO, Palvella Therapeutics

Read Bio »

Jim Moran
President & CEO, Biocoat

Read Bio »

A Legacy of Innovation

2019
Grand Opening of Coating Services Unit

Grand Opening of Coating Services Unit

To read more about our Coating Services, visit our Custom Coating Solutions section.

2019
ISO Certified

ISO Certified

Biocoat receives its ISO 13485:2016 certification.

2018
1315 Capital Acquires Biocoat

1315 Capital Acquires Biocoat

Biocoat celebrates its renewed mission to offer industry-leading custom coating solutions with its acquisition by 1315 Capital.

2018
Grand Opening & a Renewed Mission

Grand Opening & a Renewed Mission

The Rock Road facility opens, bringing the company’s total square footage to over 62,000 square feet.

2017
A Brand New Look

A Brand New Look

Biocoat undergoes a complete rebranding, better reflecting the cutting-edge technology they offer their medical device partners.

2016
Groundbreaking on a New Home

Groundbreaking on a New Home

Construction of Biocoat’s state-of-the-art Rock Road headquarters begins in Horsham, PA. The new facility, in combination with the original Witmer Road facility, means over 62,000 square feet of production capacity.

2007
PICSI<sup>®</sup> Device Released

PICSI® Device Released

Biocoat releases the revolutionary PICSI® Sperm Selection Device.

2005
The Move to Horsham

The Move to Horsham

Biocoat’s headquarters officially moves from Beaver College to its new home on Witmer Road in Horsham, PA.

2004
HBA<sup>®</sup> Released

HBA® Released

Biocoat’s proprietary Hyaluronan Binding Assay (HBA) is released to the medical device market.

2003
An End of an Era

An End of an Era

Ellington Beavers, visionary and founder of Biocoat, retires.

1994
First Products are Licensed

First Products are Licensed

Two companies license Biocoat products for commercial use.

1991
Company is Founded

Company is Founded

By Ellington Beavers at Beaver College (present day Arcadia University)

Want to talk to one of our experts about your project? Submit this form to request a consult.

Back To Top

Wes Kaupinen

President and CEO, Palvella Therapeutics

Wes Kaupinen has been on the Biocoat Board since 2017 and is the President and CEO of Palvella Therapeutics. Wes has an extensive background in M&A, business development, and capital raising, having spent time an as investment banker, venture capital investor and senior executive at a publicly traded life sciences company. Wes has extensive networks in the cardiovascular, neurovascular, peripheral vascular, ophthalmic markets as well as in the private equity arena.

Wes has an MBA degree from the Wharton School at University of Pennsylvania and a B.A. from the University of Virginia.

Matt Bastardi

SVP, Commercial & Strategy, Surgical Specialties Corporation

Matt has held senior level positions within multi-national and emerging growth medical device & diagnostics companies. His experience spans corporate development, strategic planning, sales, marketing, finance, and general management leadership roles for branded products and contract manufacturing businesses.

Currently, he is Senior Vice President, Commercial & Strategy for Surgical Specialties Corporation. Previously, Matt held various positions with Accriva Diagnostics, Covidien, Flex, and Accellent.

Matt earned an MBA from the Kellogg School of Management at Northwestern University, and a Bachelor of Science degree in Business from Georgetown University.

Michael Koby

Founding Partner, 1315 Capital

Michael Koby co-founded 1315 Capital in 2014, after spending his entire career as a healthcare investor and operator, including experience with more than 25 growth equity investments. Prior to founding 1315 Capital, Michael was a Managing Director at Palm Ventures, a private-equity focused family office where he led all healthcare investing. While at Palm, Michael led investments in Enigma Diagnostics, Axcentria Pharmaceuticals, and JDS Therapeutics. He currently serves on the boards of Biocoat, Centurion Service Group, CHC Solutions, JDS Therapeutics, and Solsys Medical.

Before Palm Ventures, Michael spent over a decade as an investor, including before and after business school, at Galen Partners, a healthcare growth equity investment firm. He also held business development roles at Novoste Corporation and Medtronic, Inc. Michael started his career as a healthcare investment banking analyst at Dillon, Read & Co.

Michael received a BSc from Cornell University and an MBA in Healthcare Management from The Wharton School.

Scott Cramer

Chairman of the Board
President & CEO, DNA Diagnostics Center

Scott has over 30 years’ experience and is a proven and focused medical device & diagnostics CEO. He has significant experience driving change by instilling a culture of high performance and implementing growth strategies as well as operational improvement initiatives, resulting in a track-record of successful exits.

Scott has served in executive level positions at Accriva Diagnostics, Warburg Pincus, Novasys Medical, Bacchus Vascular, VNUS Medical, EndoSonics (Volcano Corporation), Cardiometrics and Baxter Healthcare Corporation.

Scott holds a B.S. degree in Finance from Philadelphia University.

Greg Kleinert

Senior Director, Quality Assurance

Gregory Kleinert (Greg) is the Senior Director of Quality Assurance & Regulatory Affairs at Biocoat. In this role, Greg leads a team who is responsible for overseeing the compliance activities of worldwide quality and regulatory that include FDA and ROW regulatory agencies.

Greg joined Biocoat in 2013 and has over 25 years experience in Regulatory compliance. He has held positions in increasing roles of Compliance Management with top tier Fortune 500 companies. Greg is a frequent lecturer at local universities where he provides insight to compliance matters, auditing process and bio-ethics.

Greg holds the following certifications:
Certified Lead Auditor - ISO:13485:2016
Medical Device Quality Systems, ASQ CQA, and Management Systems Auditing.

Thomas Brugnoli

Senior Director of Operations

Thomas (Tom) Brugnoli is Biocoat’s Senior Director of Operations. Tom joined Biocoat in 2019 to lead the design and management of the Contract Coating Services unit. Tom is also responsible for the manufacturing of all coating reagents.

Tom has over 30 years of manufacturing experience which he obtained from prior operations, manufacturing and engineering services positions at Bristol-Myers Squibb and ConvaTec.

Dhruv Patel

Senior Director, Technical Sales & Services

Dhruv Patel is the Senior Director of Technical Sales & Services for Biocoat. In this role, Dhruv is responsible for assisting Biocoat’s customers during the testing, implementation and launch of medical device products that require the use of hydrophilic coatings.

Dhruv joined Biocoat in 2009 and holds a Bachelor of Science degree from the University of Mumbai, and two Masters degrees, one in Biomedical Engineering from the New Jersey Institute of Technology and the other in Business Administration from Villanova University.

Dr. Robert Hergenrother

Senior Director, Research & Development

Dr. Robert (Bob) Hergenrother is Biocoat’s Senior Director of Research and Development. In this role, Bob leads the research team in the development, maximization and exploration of new products and coating methodologies.

Bob joined Biocoat in 2017 after spending nearly 25 years in research and development roles at the Southern Research Institute, Surmodics and Boston Scientific. Bob was also a Professor in the Department of Biomedical Engineering at the University of Alabama at Birmingham.

Bob holds a Bachelor of Science degree from the University of Notre Dame and a PhD in Chemical Engineering from the University of Wisconsin-Madison.

Joe Sandora

Vice President, Business Development

Joe Sandora joined Biocoat in 2018 as Vice President of Business Development. In his role, Joe has been responsible for all domestic and international strategic relationships, contract negotiations and corporate sales strategy.

He has over 25 years in business development and senior sales management in the medical device industry having previously been with Devon Medical Products, Georgia-Pacific Professional, and ConvaTec- A Bristol Myers Squibb Company.

Joe holds a Bachelor of Arts degree in Government from St. Lawrence University.

Peg Beavers

Executive Vice President

Peg Beavers is Biocoat’s Executive Vice President. Peg is responsible for all aspects of order fulfillment, customer service and facility operations. Peg joined Biocoat in 2011 after accumulating over 10 years of experience in customer service, management and sales positions at Alstin Communications, Sprint Nextel, Pitney Bowes and AIWA America.

Peg holds a Bachelor’s degree in Psychology from Allentown College of St. Francis de Sales (present day DeSales University).

Steven Bell

Chief Financial Officer

Steven (Steve) Bell is Biocoat’s Chief Financial Officer. As CFO, Steve provides executive oversight of Biocoat’s financial and technology functions. Steven joined Biocoat in 2019 and brings 35 years of business experience that he obtained while working as a Certified Public Accountant and also as a CFO at ReSearch Pharmaceutical Services, CareScience, The MRC Group, and as a consultant providing outsourced CFO services for various middle market companies.

Steve received a Bachelor of Business Administration (BBA), Accounting from Temple University.

Jim Moran

President & CEO

Jim Moran is the President and CEO of Biocoat, Inc, a position he has held since 2018. Jim has been in the medical industry for over 25 years in various leadership, sales and marketing roles in both domestic and international assignments. Prior to joining Biocoat, he worked at Bracco Diagnostics, Acclarent, ConvaTec, TaylorMade-adidas Golf, Songbird Hearing and Vistakon. Jim also founded his own privately held medical device company called Jazz Medical in 2012 to provide advanced wound care products to the veterinary market.

Jim received a Master of Business Administration from the University of Phoenix and a Bachelor of Science in Marketing from St. Joseph’s University in Philadelphia.